𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid

✍ Scribed by Sachin R. Shah; Gary W. Jean; Sidney V. Keisner; Sarah M. Gressett Ussery; Jonathan E. Dowell

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
152 KB
Volume
20
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The impact of zoledronic acid therapy in
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
✍ Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 213 KB πŸ‘ 2 views

## Abstract Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa

The importance of oxidative stress in pa
The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis
✍ Şerafettin Demirci; Mehmet Ramazan Şekeroğlu; Tevfik Noyan; Ruşen KΓΆΓ§eroğlu; Yas πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

Increased oxidative stress is a well-known phenomenon in dialysis patients. However, the contribution of hypertension to the oxidative stress in peritoneal dialysis patients has not yet been assessed. The present study aimed to investigate if hypertension had an additional effect on oxidative stress